These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25735984)

  • 1. Cross talk between Leishmania donovani CpG DNA and Toll-like receptor 9: an immunoinformatics approach.
    Gupta CL; Akhtar S; Waye A; Pandey NR; Pathak N; Bajpai P
    Biochem Biophys Res Commun; 2015 Apr; 459(3):424-9. PubMed ID: 25735984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 9 interaction with CpG ODN--an in silico analysis approach.
    Zhou W; Li Y; Pan X; Gao Y; Li B; Qiu Z; Liang L; Zhou H; Yue J
    Theor Biol Med Model; 2013 Mar; 10():18. PubMed ID: 23497207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmanial CpG DNA nanovesicles: A propitious prophylactic approach against visceral leishmaniasis.
    Tiwari RK; Chandrakar P; Gupta CL; Sayyed U; Shekh R; Bajpai P
    Int Immunopharmacol; 2021 Jan; 90():107181. PubMed ID: 33249044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unmethylated CpG motifs in the L. donovani DNA regulate TLR9-dependent delay of programmed cell death in macrophages.
    Das S; Ghosh AK; Singh S; Saha B; Ganguly A; Das P
    J Leukoc Biol; 2015 Feb; 97(2):363-78. PubMed ID: 25473100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9.
    Fehér K
    Curr Protein Pept Sci; 2019; 20(11):1060-1068. PubMed ID: 31470785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9.
    Keestra AM; de Zoete MR; Bouwman LI; van Putten JP
    J Immunol; 2010 Jul; 185(1):460-7. PubMed ID: 20498358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impelling TLR9: Road to perspective vaccine for visceral leishmaniasis.
    Tiwari RK; Gupta CL; Bajpai P
    Drug Dev Res; 2022 Apr; 83(2):222-224. PubMed ID: 32216115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
    Latz E; Verma A; Visintin A; Gong M; Sirois CM; Klein DC; Monks BG; McKnight CJ; Lamphier MS; Duprex WP; Espevik T; Golenbock DT
    Nat Immunol; 2007 Jul; 8(7):772-9. PubMed ID: 17572678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.
    Griebel PJ; Brownlie R; Manuja A; Nichani A; Mookherjee N; Popowych Y; Mutwiri G; Hecker R; Babiuk LA
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):11-6. PubMed ID: 16098606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation.
    Peter ME; Kubarenko AV; Weber AN; Dalpke AH
    J Immunol; 2009 Jun; 182(12):7690-7. PubMed ID: 19494293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
    Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
    Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR9 agonist CpG ODN 2395 promotes the immune response against Leishmania donovani in obesity and undernutrition mice.
    He J; Huang F; Liao X; Zhang J; Wei S; Xiao Y; Zheng X; Zhu Z; Chen D; Chen J
    Acta Trop; 2023 Jun; 242():106921. PubMed ID: 37030488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
    Suwarti S; Yamazaki T; Svetlana C; Hanagata N
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
    Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
    Front Immunol; 2019; 10():179. PubMed ID: 30800129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 9 mediates CpG-DNA signaling.
    Chuang TH; Lee J; Kline L; Mathison JC; Ulevitch RJ
    J Leukoc Biol; 2002 Mar; 71(3):538-44. PubMed ID: 11867692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9.
    Ohto U; Shibata T; Tanji H; Ishida H; Krayukhina E; Uchiyama S; Miyake K; Shimizu T
    Nature; 2015 Apr; 520(7549):702-5. PubMed ID: 25686612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for species-specific activation of mouse Toll-like receptor 9.
    Ishida H; Ohto U; Shibata T; Miyake K; Shimizu T
    FEBS Lett; 2018 Aug; 592(15):2636-2646. PubMed ID: 29961984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.